×
SGLT2 inhibition does not reduce hepatic steatosis in overweight, insulin resistant patients without type 2 diabetes
Marjot T., Green C., Mcneil C., Cornfield T., Hazlehurst J., Moolla A., White S., Francis J., Neubauer S., Cobbold J., Hodson L., Tomlinson J.
DOI
10.1016/S0618-8278(19)30119-7
Type
Conference paper
Publication Date
04/2019
Volume
70
Pages
E68 - E68